Cas no 41789-38-2 (2,6-dibromo-3-(bromomethyl)pyridine)

2,6-dibromo-3-(bromomethyl)pyridine structure
41789-38-2 structure
Product Name:2,6-dibromo-3-(bromomethyl)pyridine
CAS No:41789-38-2
MF:C6H4Br3N
MW:329.814659118652
CID:927375
PubChem ID:817159
Update Time:2025-04-24

2,6-dibromo-3-(bromomethyl)pyridine Chemical and Physical Properties

Names and Identifiers

    • 2,6-dibromo-3-(bromomethyl)pyridine
    • 2,6-Dibrom-3-brommethylpyridin
    • 2,6-Dibrom-3-brommethyl-pyridin
    • 2,6-dibromo-3-bromomethyl pyridine
    • 2,6-dibromo-3-bromomethyl-pyridine
    • AC1LG8IU
    • AC1Q27OR
    • AG-F-48606
    • AR-1D4775
    • CTK4I5247
    • KB-226027
    • DB-093492
    • SCHEMBL11003617
    • 41789-38-2
    • DTXSID70355756
    • GEO-03229
    • Inchi: 1S/C6H4Br3N/c7-3-4-1-2-5(8)10-6(4)9/h1-2H,3H2
    • InChI Key: AJUZSMABBXCOER-UHFFFAOYSA-N
    • SMILES: BrCC1C(=NC(=CC=1)Br)Br

Computed Properties

  • Exact Mass: 326.78932
  • Monoisotopic Mass: 326.78939g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 10
  • Rotatable Bond Count: 1
  • Complexity: 109
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.5
  • Topological Polar Surface Area: 12.9?2

Experimental Properties

  • PSA: 12.89

2,6-dibromo-3-(bromomethyl)pyridine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A023022737-250mg
3-Bromomethyl-2,6-dibromopyridine
41789-38-2 97%
250mg
$659.60 2023-09-01
Alichem
A023022737-500mg
3-Bromomethyl-2,6-dibromopyridine
41789-38-2 97%
500mg
$1009.40 2023-09-01
Alichem
A023022737-1g
3-Bromomethyl-2,6-dibromopyridine
41789-38-2 97%
1g
$1646.40 2023-09-01

Additional information on 2,6-dibromo-3-(bromomethyl)pyridine

Comprehensive Guide to 2,6-Dibromo-3-(bromomethyl)pyridine (CAS No. 41789-38-2): Properties, Applications, and Market Insights

2,6-Dibromo-3-(bromomethyl)pyridine (CAS No. 41789-38-2) is a halogenated pyridine derivative that has garnered significant attention in the chemical and pharmaceutical industries. This compound, characterized by its unique bromine substitutions, serves as a versatile intermediate in organic synthesis. Researchers and manufacturers are increasingly interested in 2,6-dibromo-3-(bromomethyl)pyridine applications due to its potential in creating complex molecular structures. In this article, we delve into its properties, synthesis methods, and emerging uses, while addressing common queries like "how to synthesize 2,6-dibromo-3-(bromomethyl)pyridine" and "where to buy 2,6-dibromo-3-(bromomethyl)pyridine."

The molecular structure of 2,6-dibromo-3-(bromomethyl)pyridine features three bromine atoms strategically positioned on a pyridine ring, enhancing its reactivity in cross-coupling reactions. This property makes it invaluable in the synthesis of agrochemicals, pharmaceuticals, and specialty chemicals. Recent studies highlight its role in developing pyridine-based catalysts, a hot topic in green chemistry. As industries shift toward sustainable practices, the demand for brominated pyridine derivatives like this compound is expected to rise, particularly in regions with stringent environmental regulations.

One of the most searched questions about CAS 41789-38-2 pertains to its safety profile and handling. While not classified as hazardous under standard conditions, proper storage in cool, dry environments is recommended to maintain stability. Laboratories often inquire about "2,6-dibromo-3-(bromomethyl)pyridine solubility"—it exhibits moderate solubility in organic solvents like dichloromethane and THF, but limited solubility in water. These characteristics are crucial for researchers designing reaction protocols or purification processes.

The pharmaceutical industry has shown growing interest in 2,6-dibromo-3-(bromomethyl)pyridine as a building block for drug discovery. Its ability to undergo selective functionalization makes it ideal for creating heterocyclic compounds with potential therapeutic effects. Recent patent filings reveal its use in developing kinase inhibitors, aligning with the global focus on targeted cancer therapies. This connection to medicinal chemistry trends positions the compound as a valuable asset in R&D pipelines.

Market analysis indicates steady growth for brominated pyridine intermediates, driven by advancements in material science and electronics. The compound's role in synthesizing organic electronic materials responds to the booming demand for flexible displays and energy-efficient devices. Manufacturers seeking "high-purity 2,6-dibromo-3-(bromomethyl)pyridine" often prioritize suppliers with rigorous quality control, reflecting the compound's importance in precision applications.

From an environmental standpoint, researchers are exploring greener synthesis routes for 2,6-dibromo-3-(bromomethyl)pyridine to reduce bromine waste. This aligns with the "sustainable bromination methods" trend in academic literature. Innovations in catalytic bromination and solvent recovery systems could enhance the compound's appeal to eco-conscious industries, addressing common search queries about "environmentally friendly halogenated compounds."

Analytical techniques for characterizing 2,6-dibromo-3-(bromomethyl)pyridine frequently appear in technical discussions. GC-MS, HPLC, and NMR are standard methods for verifying purity—a critical consideration for buyers comparing "CAS 41789-38-2 specifications." The compound's distinct spectral signatures (particularly in 1H NMR) serve as valuable teaching examples in spectroscopy courses, linking it to chemical education resources.

Looking ahead, the versatility of 2,6-dibromo-3-(bromomethyl)pyridine ensures its relevance across multiple sectors. Whether as a precursor for advanced materials or a tool in pharmaceutical research, this compound exemplifies how specialized intermediates drive innovation. Suppliers and researchers alike monitor developments in "halogenated heterocycle markets" to anticipate demand shifts and technological breakthroughs.

Recommended suppliers
Jiangsu Xinsu New Materials Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangsu Xinsu New Materials Co., Ltd
Shanghai Aoguang Biotechnology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Aoguang Biotechnology Co., Ltd
Changzhou Guanjia Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Changzhou Guanjia Chemical Co., Ltd
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.